SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001493152-19-004590
Filing Date
2019-04-01
Accepted
2019-04-01 17:11:50
Documents
77
Period of Report
2018-12-31

Document Format Files

Seq Description Document Type Size
1 form10-k.htm 10-K 1750462
2 ex23-1.htm EX-23.1 3360
3 ex31-1.htm EX-31.1 20490
4 ex32-1.htm EX-32.1 9851
  Complete submission text file 0001493152-19-004590.txt   6128332

Data Files

Seq Description Document Type Size
5 XBRL INSTANCE FILE aker-20181231.xml EX-101.INS 859024
6 XBRL SCHEMA FILE aker-20181231.xsd EX-101.SCH 76225
7 XBRL CALCULATION FILE aker-20181231_cal.xml EX-101.CAL 72041
8 XBRL DEFINITION FILE aker-20181231_def.xml EX-101.DEF 266739
9 XBRL LABEL FILE aker-20181231_lab.xml EX-101.LAB 517535
10 XBRL PRESENTATION FILE aker-20181231_pre.xml EX-101.PRE 372810
Mailing Address 201 GROVE RD THOROFARE NJ 08086
Business Address 201 GROVE RD THOROFARE NJ 08086 856-848-8698
Akers Biosciences, Inc. (Filer) CIK: 0001321834 (see all company filings)

IRS No.: 000000000 | State of Incorp.: NJ | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-36268 | Film No.: 19721734
SIC: 2835 In Vitro & In Vivo Diagnostic Substances